British Journal of Clinical Pharmacology · 1991 · 69 citations · 9 references
PharmacyPharmacokineticsPharmacologyBioavailabilityClinical PharmacologyGeneral PharmacologyDrug DispositionMultiple-dose Bioequivalence StudiesMultiple-dose PharmacokineticsPharmacokinetic ParametersRandomized Crossover DesignsRandomized Crossover TrialsSerum Digoxin ConcentrationSingle-dose Administration
1. The influence of multiple dose administration of omeprazole on the pharmacokinetics of oral digoxin was studied in 10 healthy male volunteers. 2. In a randomized two-way crossover design a single dose of 1 mg digoxin was administered either alone (control) or on day 8 of an 11 day course of omeprazole 20 mg once daily. 3. Plasma digoxin concentrations were measured over 96 h after digoxin administration with a [125I]-r.i.a. method. 4. On average, Cmax and AUC values for digoxin were approximately 10% higher and tmax tended to be shorter during the administration of omeprazole, while the elimination rate constant was unaffected. 5. The increase in AUC(0,96 h) was statistically significant (P less than 0.05), but within the accepted range for bioequivalence. In two subjects the increase was approximately 30%. 6. It is concluded that co-treatment with omeprazole causes a minor increase in the absorption of oral digoxin. The magnitude of this effect is not considered to be clinically relevant for the majority of patients.
9
Influence of Gastric Acidity on the Bioavailability of Digoxin
Adam F. Cohen, Ria Kroon, Rik C. Schoemaker et al. · Annals of Internal Medicine · 1991 · 33 citations
Dose-independent pharmacokinetics of digoxin in humans
Hermann R. Ochs, David J. Greenblatt, G. Bodem et al. · American Heart Journal · 1978 · 31 citations